IP Library › Granted Patent US 9,926,268
Granted Patent B2
US 9,926,268 · App. 15/317,297 · Granted Mar 27, 2018

Method for preparing azetidinone compound and intermediate of azetidinone compound

Inventors: Hua Bai (Taizhou, CN); Xuyang Zhao (Chengdu, CN); Yuncai Zhang (Taizhou, CN); Xufei Li (Taizhou, CN); Yong Zhang (Zhejiang, CN); Dezhou Xu (Taizhou, CN); Li Zhang (Taizhou, CN); Xiaojie Xu (Taizhou, CN); Qifeng Zhu (Taizhou, CN); Xiaoming Wang (Taizhou, CN); Zhiqing Yang (Taizhou, CN); Zehua Zhong (Taizhou, CN); Jian Zhang (Taizhou, CN)
Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.
C07D205/08C07C51/367C07C59/56C07C67/30C07C67/327C07C67/343C07C69/65C07C69/732
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,926,268
App. No.
15/317,297
Granted
Mar 27, 2018
Kind
B2
Abstract

Disclosed is a new method for preparing an azetidinone compound represented by formula (I). The carboxylic ketoester represented by formula (II) serves as the raw material and is subjected to Grignard addition, stereoselective dehydration, ester group reduction, hydroxyl group protection, addition with imine after condensation with a chiral auxiliary, cyclization and deprotection to obtain the compound represented by formula (I). The present invention has advantages of easily available raw material, a few synthetic steps, simple operation, high yield, good stereoselectivity and low cost, and can be used for industrial production.

Claims (9)

1. A compound of formula V:

2. A method for preparing the compound of claim 1 , comprising: selectively reducing the ester of formula IV to the alcohol of formula V under the action of a reducing agent:

wherein R 1 is C 1 -C 6 alkyl.

3. The method according to claim 2 , wherein a solvent used in reducing the ester of formula IV to the alcohol of formula V is selected from dichloromethane, tetrahydrofuran, toluene or dioxane.

4. The method according to claim 2 , wherein the reducing agent is diisobutylaluminium hydride (DIBAH).

5. The method according to claim 2 , wherein a molar ratio of the compound of formula IV to the reducing agent is 1:2.5˜5.0.

6. The method according to claim 1 , wherein in the ester of formula IV, R 1 is methyl, ethyl or isopropyl.

7. The method according to claim 1 , wherein a solvent used in reducing the ester of formula IV to the alcohol of formula V is toluene.

8. The method according to claim 1 , wherein a molar ratio of the compound of formula IV to the reducing agent is 1:3.0˜4.0.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2016
From: BAI, HUA; ZHAO, XUYANG; ZHANG, YUNCAI; LI, XUFEI; ZHANG, YONG; XU, DEZHOU; ZHANG, LI; XU, XIAOJIE; ZHU, QIFENG; WANG, XIAOMING; YANG, ZHIQING; ZHONG, ZEHUA; ZHANG, JIAN
To: ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
Reel/Frame 040732/0013 →
Priority Claims (1)
CN 2014 1 0251262 · Jun 9, 2014 · national
Continuity (1)
Related Publication 20170121281A1 · May 4, 2017